XHKG
9600
Market cap16mUSD
Jul 10, Last price
0.13HKD
1D
0.00%
1Q
-36.84%
IPO
-97.01%
Name
Newlink Technology Inc
Chart & Performance
P/E
—
P/S
0.37
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.23%
Rev. gr., 5y
11.88%
Revenues
309m
+10.73%
Net income
-188m
L+103.26%
CFO
-13m
L
Dividend
Jun 14, 20230.04 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Newlink Technology Inc., an investment holding company based in Beijing, China, focuses on providing solutions leveraging big data analytics and artificial intelligence. Its operations are divided into three main segments: Financial Institutions, Medical Institutions, and Other. The company's offerings include software engineering, technical support, and maintenance services, alongside the sale of proprietary software products. Notably, they provide robotic process automation (RPA) systems, integrated RPA machinery, and intelligent management platforms built upon medical and health big data. Their portfolio also extends to specialized solutions such as medical quality assurance and safety alert platforms, clinical pathway optimization systems, smart healthcare platforms, and remote medical services. Newlink Technology serves a diverse client base, encompassing financial sector entities like banks, trust companies, and asset management firms, as well as healthcare providers such as hospitals, among other customers. The company was founded in 2011.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||